fbpx

Day

November 18, 2020
SAN DIEGO and COPENHAGEN, Denmark, Nov. 18, 2020 /PRNewswire/ — AFYX Therapeutics (“AFYX”), a clinical-stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced the appointment of Dennis D. Kim, M.D., MBA, as chief medical officer. Dr. Kim will lead the clinical development of Rivelin®-Clobetesol for the treatment of oral lichen planus, Rivelin®-Mometasone for...

News

Danish researchers provide proof: Caesarean sections can lead to asthma and allergies
12. November 2020
Brand-new medical treatment for cocaine addiction
10. November 2020
90 million to 18 Talented Researchers
19. October 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge